GMX1777
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GMX1777, covering 2013-08-28 to 2016-07-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma [Phase 1, Phase 2]